Maximino
Abraldes Lopez-Veiga
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublications in collaboration with researchers from Hospital Universitari de Bellvitge (5)
2024
-
Fight Retinal Blindness SPAIN. Report 3: clinical outcomes of vascular endothelial growth factor inhibitors in low vision eyes with neovascular age-related macular degeneration. A national database study
Eye (Basingstoke)
-
Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular Degeneration
Ophthalmology Retina, Vol. 8, Núm. 4, pp. 350-359
2021
-
Economic burden of age-related macular degeneration in routine clinical practice: the RAMDEBURS study
International Ophthalmology, Vol. 41, Núm. 10, pp. 3427-3436
2018
-
Association between CFH, CFB, ARMS2, SERPINF1, VEGFR1 and VEGF polymorphisms and anatomical and functional response to ranibizumab treatment in neovascular age-related macular degeneration
Acta Ophthalmologica, Vol. 96, Núm. 2, pp. e201-e212
-
Clinical decision-making when treating diabetic macular edema patients with dexamethasone intravitreal implants
Ophthalmologica, Vol. 240, Núm. 2, pp. 61-72